What is Projetc Shivom?
Shivom is powering the next era of genomics through blockchain technology – by protecting identity, personalizing healthcare, transforming lives. Our blockchain based genomics and healthcare platform will allow the transition to value-based precision healthcare. Our focus is on the transformational convergence of OMICS technologies with blockchain, artificial intelligence and machine learning to enable secure and personalized medicine with global scalability.
Shivom’s Plan To Revolutionize Genetic Data Handling
The blockchain technology is currently the leading technology regarding solving our privacy issues. The ability to deliver secure transactions without intermediaries is proving useful in many industries including real estate, finance, health and now genomics. It is evident that already several wellness companies are betting on the need for genomic data and investing in genomic data venture to meet the growth.
Shivom is one such venture that intends to utilize the securitization of data within blockchain technology to empower a new era of genomics. The healthcare platform will allow for a genomic ecosystem where users will have an open web marketplace for personalized medicine, genomic data analytics, and health services applications.
The team behind the project envision a transformational convergence of the OMICS technologies with AI, machine learning techniques, and blockchain to allow for the global scalability in healthcare.
Shivom Platform
Genomics and artificial intelligence show a novel chance to reform R&D programs, particularly screening for medicate targets and comparing drug hopefuls. The critical cost related with tranquilize advancement is connected to the capacity to get to high caliber and approved datasets from patients. We are as of now captivating with accomplices in driving pharmaceutical/biotech organizations and clinical research associations (CROs) to enable access to our administrations, and in addition offer the chance to support genomic testing on a mass level. The information won't be claimed by any organization, and the Shivom stage will encourage pharmaceutical organizations' utilization of the information by giving alluring rewards and a market get to display that straightforwardly draws in with information proprietors. The model will enable access to study and control patients through an application commercial center for phenotypic screening and that's only the tip of the iceberg.
Our Vision
Accelerate the era of genomics
Each of the 7.6 billion people on earth has a unique code enclosed in their genes that unlocks the secrets of appearance, origins, intellectual abilities, health and fitness. But the ability of this code to reveal the predisposition to the disease has been neglected.
Improve global health
Now is the time for a concerted community-wide development for the "genomics" challenges of the next decade. Currently, some key players hold a monopoly on genomic data and make huge profits from selling to third parties, usually without sharing earnings with the donor.
Jumpstart precision medicine based on the genome
We are changing the dynamics of the global healthcare market. We are using the most advanced technologies including blockchain, cloud computing, genome sequencing, artificial intelligence and big data analysis to bring medical genomics into a new era.
Ensure the next level of data privacy
We are at the forefront of data security. We use advanced cryptography to add additional levels of security to our platform that go beyond blockchain decentralization technology, protecting each user's data from cyber criminals
Genomics for all is the basis of the Vhisom Project and one of its goals is to improve overall health and as a true test of founder Sally Eaves, dr. Axel Schumacher and Gourish Singla visit rural communities in India to talk to the local people about their health care challenges and opportunities in which genome technology can make a difference.
What Shivom Aims To Solve
- The expensive procedure of genome sequencing
- Lack of data ownership, integrity and sharing capabilities
- The sale of genomic data by third-party genomic sequencing providers.
- Lacks doctor-patient confidentiality
- No compensation measure for patients regarding the use of their data by health institutions and researchers.
Shivom's Solution
To achieve its goal of a universal database for DNA sequences, Shivom will utilize the blockchain technology to create a genuine, and autonomous ecosystem. With this ideology, Shivom will protect the sensitive genomic data which is yet to happen with our traditional databases. As such, the healthcare sector is set to enjoy a set of benefits that come with overcoming the challenge of a safe system. These will include;
- Easier access and storage of the genome data in one place
- Better management and control of how the information is accessed
- Health researchers can use the information to find lifestyle information
- The potential to identify health conditions before they become serious
- Enables the user to get value for their data through tokenization and smart contracts
The Negatives
Although the Shivom platform would sound all too interesting, all the concepts are just on papers, and there is nothing that goes to show for the venture. No proof of concept of product development is taking place and the only indication is a release set to take place in the Q2 of 2018.
Additionally, their partnerships announcement is somewhat falsified since there is little evidence to reveal any partnerships company claiming to be working with Shivom. Public searches also do not show any associations involving the blockchain ventures.
Another point of concern is the claim to work in conjunction with governments to get the whole population genetically sequenced. For starters, that is a rather ambitious project with regards to the government regulation facing the use of blockchain. The numbers also seem too high regarding tokens and could dilute the value after the ICO.
Is It Wise To Invest in Shivom?
Judging from the negative point I have raised, the project does not sound of investment quality. However, the overall concept of the platform is unique, and the venture could face a revisit if the inefficiencies get the adequate solutions.
In conclusion for this stage, there is not enough information regarding the Shivom project. There is little information on the part of their operations and supposed partnerships or advisors. As such, I would not recommend on putting your investment in such a project.
TEAM
 |
| DR. AXEL SCHUMACHER CO- FOUNDER & CEO |
 |
| GOURISH SINGLA CO- FOUNDER & COO |
 |
| COUL FOUNDER & CMO SALLY EAVES |
 |
| CO- FOUNDER E CSO PER LIND |
Roadmap
Contacts
The developers can be contacted using the link below:
ETH Address : 0x4be0D62Fc296136326F1A6BB6E3A543472c41820
0 Response to "Shivom: The Next Era of Genomics and Healthcare (ICO REVIEW)"
Post a Comment